메뉴 건너뛰기




Volumn 47, Issue 33, 2000, Pages 862-865

A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer

Author keywords

5 Fluorouracil; Chemotherapy; Methotrexate; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; METHOTREXATE;

EID: 0034049718     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (14)

References (19)
  • 1
    • 0020544962 scopus 로고
    • Sequential methotrexate and 5-fluorouracil treatment of squamous cell carcinoma of the head and neck
    • 1 Ringborg U, Ewert G, Kinnman J, Lundqvist PG, Strander H: Sequential methotrexate and 5-fluorouracil treatment of squamous cell carcinoma of the head and neck. Cancer 1983; 52:971-973.
    • (1983) Cancer , vol.52 , pp. 971-973
    • Ringborg, U.1    Ewert, G.2    Kinnman, J.3    Lundqvist, P.G.4    Strander, H.5
  • 2
    • 0019431215 scopus 로고
    • Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer
    • 2 Gewirtz AM, Cadman E: Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer 1981; 47:2552-2555.
    • (1981) Cancer , vol.47 , pp. 2552-2555
    • Gewirtz, A.M.1    Cadman, E.2
  • 7
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • 7 Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 63:457-481.
    • (1958) J Am Stat Assoc , vol.63 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 8
    • 0023880296 scopus 로고
    • Continuous 5-fluorouracil (5-FU) infusion in carcinoma of the pancreas: A phase II study
    • 8 Hansen R, Quebbeman E, Ritch P, Chitambar C, Anderson T: Continuous 5-fluorouracil (5-FU) infusion in carcinoma of the pancreas: A phase II study. Am J Med Sci 1988; 295:91-93.
    • (1988) Am J Med Sci , vol.295 , pp. 91-93
    • Hansen, R.1    Quebbeman, E.2    Ritch, P.3    Chitambar, C.4    Anderson, T.5
  • 9
    • 0026010878 scopus 로고
    • Phase II study of continuous venous infusion of 5-fluorouracil in advanced pancreatic cancer
    • 9 Tajiri H,Yoshimori M, Okazaki N. Miyaji M: Phase II study of continuous venous infusion of 5-fluorouracil in advanced pancreatic cancer. Oncology 1991; 48:18-21.
    • (1991) Oncology , vol.48 , pp. 18-21
    • Tajiri, H.1    Yoshimori, M.2    Okazaki, N.3    Miyaji, M.4
  • 10
    • 0025841867 scopus 로고
    • Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: Results of a phase II trial
    • 10 DeCaprio JA, Mayer RJ, Gonin R, Arbuck SG: Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial. J Clin Oncol 1991; 9:2128-2133.
    • (1991) J Clin Oncol , vol.9 , pp. 2128-2133
    • DeCaprio, J.A.1    Mayer, R.J.2    Gonin, R.3    Arbuck, S.G.4
  • 11
    • 0025815267 scopus 로고
    • Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma
    • 11 Crown J, Casper ES, Botet J, Murray P, Kelsen DP: Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol 1991; 9:1682-1686.
    • (1991) J Clin Oncol , vol.9 , pp. 1682-1686
    • Crown, J.1    Casper, E.S.2    Botet, J.3    Murray, P.4    Kelsen, D.P.5
  • 12
  • 13
    • 0026738325 scopus 로고
    • A phase II trial of 5-fluorouracil, leuovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas
    • 13 Scheithauer W, Pfeffel F, Kornek G, Marczell A, Wiltschke C, Funovics J: A phase II trial of 5-fluorouracil, leuovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas. Cancer 1992; 70:1864-1866.
    • (1992) Cancer , vol.70 , pp. 1864-1866
    • Scheithauer, W.1    Pfeffel, F.2    Kornek, G.3    Marczell, A.4    Wiltschke, C.5    Funovics, J.6
  • 14
    • 0025941816 scopus 로고
    • A phase I, II study of high dose 5-fluorouracil and high-dose leucovorin with low dose phosphonacelyl-I-aspartic acid in patients with advanced malignancies
    • 14 Ardalan B, Sridhar KS, Benedetto P, Richman S, Waldman S, Morrell L, Feun L, Savaraj N, Fodor M, Livingstone A: A phase I, II study of high dose 5-fluorouracil and high-dose leucovorin with low dose phosphonacelyl-I-aspartic acid in patients with advanced malignancies. Cancer 1991; 68: 1242-1246.
    • (1991) Cancer , vol.68 , pp. 1242-1246
    • Ardalan, B.1    Sridhar, K.S.2    Benedetto, P.3    Richman, S.4    Waldman, S.5    Morrell, L.6    Feun, L.7    Savaraj, N.8    Fodor, M.9    Livingstone, A.10
  • 15
    • 0018700143 scopus 로고
    • Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: Explanation for drug synergism
    • 15 Cadman E, Heimer R, Davis L: Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: Explanation for drug synergism. Science 1979; 205:1135-1137.
    • (1979) Science , vol.205 , pp. 1135-1137
    • Cadman, E.1    Heimer, R.2    Davis, L.3
  • 16
    • 0019804957 scopus 로고
    • The role of methotrexate and dihydrofolate polyglutamates in enhancement of fluorouracil action by methotrexate
    • 16 Fernandes DJ, Moroson BA, Bertino JR: The role of methotrexate and dihydrofolate polyglutamates in enhancement of fluorouracil action by methotrexate. Cancer Treat Rep 1981; 65:29-35.
    • (1981) Cancer Treat Rep , vol.65 , pp. 29-35
    • Fernandes, D.J.1    Moroson, B.A.2    Bertino, J.R.3
  • 17
    • 0030780051 scopus 로고    scopus 로고
    • Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma
    • 17 Harstrick A, Kohne CH, Hiddemann W, Preusser P, Strumberg D, Berns T, Seeber S, Wilke H, Schmoll HJ: Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma. Ann Oncol 1997:8:917-918.
    • (1997) Ann Oncol , vol.8 , pp. 917-918
    • Harstrick, A.1    Kohne, C.H.2    Hiddemann, W.3    Preusser, P.4    Strumberg, D.5    Berns, T.6    Seeber, S.7    Wilke, H.8    Schmoll, H.J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.